These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6295008)

  • 41. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J
    Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regions of the EBV genome involved in latency and lymphocyte immortalization.
    Miller G
    Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
    [No Abstract]   [Full Text] [Related]  

  • 45. Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.
    Patel PC; Dorval G; Menezes J
    Infect Immun; 1982 Oct; 38(1):251-9. PubMed ID: 6292093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis.
    Falk K; Ernberg I; Sakthivel R; Davis J; Christensson B; Luka J; Okano M; Grierson HL; Klein G; Purtilo DT
    Int J Cancer; 1990 Dec; 46(6):976-84. PubMed ID: 2174416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    Miller G; Coope D; Niederman J; Pagano J
    J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M; Fridman WH; Tursz T; Vincent C; Pious D; Fellous M
    J Exp Med; 1979 Dec; 150(6):1310-22. PubMed ID: 229186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus-transformed human B lymphocytes endocytose autologous and heterologous red blood cells.
    Garzelli C; Marchetti A; Pacciardi A; Puglisi C; Basolo F
    Int Arch Allergy Appl Immunol; 1989; 88(3):312-6. PubMed ID: 2542165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation.
    Schooley RT; Haynes BF; Payling-Wright CR; Grouse JE; Dolin R; Fauci AS
    Cell Immunol; 1980 Dec; 56(2):518-25. PubMed ID: 6258810
    [No Abstract]   [Full Text] [Related]  

  • 51. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
    Nikiforow S; Bottomly K; Miller G
    J Virol; 2001 Apr; 75(8):3740-52. PubMed ID: 11264363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sites of Epstein-Barr virus replication in acute and chronic active Epstein-Barr virus infections.
    Kikuta H; Osato T; Matsumoto S
    Intervirology; 1989; 30(6):346-50. PubMed ID: 2559902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA
    J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pathogenesis of infectious mononucleosis.
    McCue JD
    Hosp Pract (Off Ed); 1982 Oct; 17(10):34, 34A-F, 34J-M. PubMed ID: 6288544
    [No Abstract]   [Full Text] [Related]  

  • 55. The Effects of Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) on B-Lymphocytic Activity.
    Qu M; Ding F; Di S; Zhang S; Yu X
    Clin Lab; 2018 Apr; 64(4):425-431. PubMed ID: 29739075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.
    Hochberg D; Souza T; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
    J Virol; 2004 May; 78(10):5194-204. PubMed ID: 15113901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A positive correlation between the precursor frequency of cytotoxic lymphocytes to autologous Epstein-Barr virus-transformed B cells and antibody titer level against Epstein-Barr virus-associated nuclear antigen in healthy seropositive individuals.
    Kusunoki Y; Huang H; Fukuda Y; Ozaki K; Saito M; Hirai Y; Akiyama M
    Microbiol Immunol; 1993; 37(6):461-9. PubMed ID: 8231961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infectious mononucleosis fifty years after the discovery of the Paul-Bunnell test.
    Burgio GR; Monafo V
    Infection; 1983; 11(1):1-5. PubMed ID: 6302006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response.
    Wallace LE; Rickinson AB; Rowe M; Moss DJ; Allen DJ; Epstein MA
    Cell Immunol; 1982 Feb; 67(1):129-40. PubMed ID: 6176332
    [No Abstract]   [Full Text] [Related]  

  • 60. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state.
    Prang NS; Hornef MW; Jäger M; Wagner HJ; Wolf H; Schwarzmann FM
    Blood; 1997 Mar; 89(5):1665-77. PubMed ID: 9057649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.